a developer of gene-based medicines
Industry Biotechnology
A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To CRSP | 1D Price Change % | ||
---|---|---|---|---|
CRSP | 100% | -4.61% | ||
BEAM - CRSP | 72% Closely correlated | -8.55% | ||
NTLA - CRSP | 71% Closely correlated | -3.65% | ||
EDIT - CRSP | 66% Closely correlated | -6.68% | ||
RXRX - CRSP | 56% Loosely correlated | -16.62% | ||
PRME - CRSP | 55% Loosely correlated | -9.81% | ||
More |
Ticker / NAME | Correlation To CRSP | 1D Price Change % |
---|---|---|
CRSP | 100% | -4.61% |
gene-based medicines theme (3 stocks) | 99% Closely correlated | +0.40% |
CRSP theme (4 stocks) | 94% Closely correlated | +0.86% |
drugs theme (265 stocks) | 62% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 58% Loosely correlated | +5.56% |
europe theme (180 stocks) | 49% Loosely correlated | +0.17% |
More |